Pulmatrix, Inc.
corporate_fare Company Profile
Pulmatrix, Inc. (NASDAQ:PULM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for PULM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-25, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 13 rated 8 or above. Recent SEC coverage for PULM spans DEFM14A, S-4/A, 10-Q, 8-K.
Recent high-impact activity:
- Pulmatrix Mails Definitive Proxy for Eos SENOLYTIX Reverse Merger Vote on October 16
- Pulmatrix Sets October 16 Vote on Eos SENOLYTIX Reverse Merger, Updates Exchange Ratio to 8.55
- Pulmatrix Sets October 2 Vote on Eos SENOLYTIX Reverse Merger; Legacy Holders to Own Just 6%
- Pulmatrix Q2 Loss Narrows to $1.04M as Cash Drops to $2.2M; Merger with Eos SENOLYTIX Expected Q3
- Pulmatrix Q2 10-Q: Going Concern Warning, Cash Down to $2.2M, Merger Critical
Financial Snapshot
Short Interest & Short Volume
1.27 days to coverFINRA reported short interest of 55,391 shares in PULM as of the September 15, 2026 settlement, a 174.2% increase from the prior period — about 1.3 days to cover at its recent average daily volume. On October 2, 2026, 17.4% of PULM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for PULM, detected from its recent SEC filings · based on capital-structure filings through 2026-09-25.
Registration for Resale · Source of Shares
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →